- Home
- SVA vs ACGLO Comparison
SVA vs ACGLO Comparison
Compare SVA & ACGLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVA
- ACGLO
- Stock Information
- Founded
- SVA N/A
- ACGLO N/A
- Country
- SVA
- ACGLO Bermuda
- Employees
- SVA 3261
- ACGLO 5800
- Industry
- SVA
- ACGLO Property-Casualty Insurers
- Sector
- SVA
- ACGLO Finance
- Exchange
- SVA NYSE
- ACGLO Nasdaq
- Market Cap
- SVA N/A
- ACGLO N/A
- IPO Year
- SVA N/A
- ACGLO N/A
- Fundamental
- Price
- SVA $6.47
- ACGLO $21.64
- Analyst Decision
- SVA
- ACGLO
- Analyst Count
- SVA 0
- ACGLO 0
- Target Price
- SVA N/A
- ACGLO N/A
- AVG Volume (30 Days)
- SVA N/A
- ACGLO N/A
- Earning Date
- SVA N/A
- ACGLO N/A
- Dividend Yield
- SVA N/A
- ACGLO N/A
- EPS Growth
- SVA N/A
- ACGLO N/A
- EPS
- SVA N/A
- ACGLO N/A
- Revenue
- SVA N/A
- ACGLO N/A
- Revenue This Year
- SVA N/A
- ACGLO N/A
- Revenue Next Year
- SVA N/A
- ACGLO N/A
- P/E Ratio
- SVA N/A
- ACGLO N/A
- Revenue Growth
- SVA N/A
- ACGLO N/A
- 52 Week Low
- SVA N/A
- ACGLO N/A
- 52 Week High
- SVA N/A
- ACGLO N/A
- Technical
- Relative Strength Index (RSI)
- SVA N/A
- ACGLO 47.28
- Support Level
- SVA N/A
- ACGLO $21.62
- Resistance Level
- SVA N/A
- ACGLO $22.12
- Average True Range (ATR)
- SVA 0.00
- ACGLO 0.25
- MACD
- SVA 0.00
- ACGLO 0.00
- Stochastic Oscillator
- SVA 0.00
- ACGLO 42.86
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.
About ACGLO Arch Capital Group Ltd. Depositary Shares Each Representing 1/1000th Interest in a Share of 5.45% Non-Cumulative Preferred Shares Series F
Arch Capital Group Ltd is a Bermuda company which writes insurance and reinsurance with operations in Bermuda, the United States, Canada, Europe, Australia and United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage two operating segments: corporate and other. The insurance segment provides specialty risk solutions to client across a variety of industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.